New registry aims to unlock secrets of rare blood cancers
NCT ID NCT07561385
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a registry that will collect medical information and blood samples from 500 adults with myelodysplastic syndromes (MDS) and related conditions. The goal is to learn more about how these diseases develop and progress over time. Participants will not receive any experimental treatment, but their data will help researchers better understand these rare blood disorders.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, 01307, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill boost the power of an existing leukemia treatment?
- Personalized dosing may improve stem cell transplant survival in blood cancer patients
- Could bone marrow from deceased donors cure blood cancers?
- New blood test may predict cancer relapse after transplant
- New hope for blood cancer patients: daily pill aims to prevent relapse without transplant
- New stem cell combo could boost survival in blood cancer patients